Brimonidine eye drops for slowing nearsightedness in children
Part of Eyes & vision clinical trials.
This trial tests whether brimonidine eye drops can slow down worsening nearsightedness (myopia) in children. It aims to find a non-invasive way to help prevent vision from getting more nearsighted.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 6 and 14 years old.
- Your nearsightedness must be between -1.50 and -5.50 diopters (a measure of prescription strength).
- You must not have any other eye conditions besides myopia.
- You must not have had previous myopia treatment with eye drops, contact lenses, or special glasses.
- You must not have significant differences in vision between your two eyes (amblyopia).
- Before starting, you must have a negative urine pregnancy test if you are of childbearing age, and agree to use effective contraception during and for 6 months after treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new eye drop medicine (T10430) to see if it can slow down how fast children's nearsightedness gets worse. The trial will measure whether the drops are safe and effective for kids ages 6–11.
This study tests whether special glasses or low-dose atropine eye drops can slow down worsening nearsightedness in children. It compares four groups: glasses alone, eye drops alone, both together, or a placebo (no active treatment).
This study tests an eye drop (QLM3004) to see if it can slow down the progression of nearsightedness (myopia) in children. It might be a good option if your child is between 6 and 12, has mild to moderate nearsightedness, and hasn't used other myopia treatments before.
This trial tests whether atropine eye drops can slow down worsening nearsightedness (myopia) in children and teenagers. It may help keep their eyesight from getting worse over time.
This study tests whether a very low-dose atropine eye drop (0.01%) can safely slow down worsening nearsightedness in children. It is for kids ages 3 to 12 who are already nearsighted but haven't used other myopia control treatments before.
This trial tests whether atropine eye drops can reduce the progression of myopia (nearsightedness, where you have trouble seeing far away) in children. It might help slow down the worsening of vision over time.
Hear when a new Myopia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.